Chinese baby formula manufacturer Biostime International plans to restructure its balance sheet through a tender offer of its outstanding HK$3.1 billion ($400 million) convertible debt and a new Reg S/144A senior bond issue, the company said on Monday.
¬ Haymarket Media Limited. All rights reserved.
